Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Obesity × penclomedine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1 Polycystic Ovary Syndrome 1 Obesity 1 Fatty Liver 1

Interventions

Exercise 22 Metformin 14 Tirzepatide 8 Diet 8 Resistance Training 7 Nutrition Assessment 7 Methods 7 Diet Therapy 7 Counseling 6 semaglutide 5 Exenatide 5 Early Intervention, Educational 5 Diet, Mediterranean 5 Caloric Restriction 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Liraglutide 4 Educational Status 4 Bariatric Surgery 4 Vitamin D 3 Standard of Care 3 Naltrexone 3 Letrozole 3 Docosahexaenoic Acids 3 Dexamethasone 3 Bupropion 3 exemestane 2 bupropion hydrochloride, naltrexone hydrochoride drug combination 2 Yoga 2 Topiramate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02157974 2024-06-04

APPLE

University of Colorado, Denver

Phase 2/3 Completed

92 enrolled 17 charts

Fatty Liver, Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡